| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.61e-05 | 303 | 24 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.73e-04 | 562 | 24 | 5 | GO:0003712 | |
| GeneOntologyCellularComponent | midbody | 1.11e-04 | 222 | 24 | 4 | GO:0030496 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.81e-04 | 34 | 15 | 2 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.89e-04 | 37 | 15 | 2 | M27797 | |
| Pubmed | 5.10e-07 | 1116 | 24 | 8 | 31753913 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.67e-06 | 154 | 24 | 4 | 16055720 | |
| Pubmed | 5.87e-06 | 689 | 24 | 6 | 36543142 | ||
| Pubmed | 6.88e-06 | 399 | 24 | 5 | 35987950 | ||
| Pubmed | 8.24e-06 | 57 | 24 | 3 | 38223760 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 9.99e-06 | 431 | 24 | 5 | 33660365 | |
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 2.05e-05 | 10 | 24 | 2 | 32669118 | |
| Pubmed | 3.24e-05 | 268 | 24 | 4 | 33640491 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.28e-05 | 934 | 24 | 6 | 33916271 | |
| Pubmed | 3.64e-05 | 1429 | 24 | 7 | 35140242 | ||
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 4.13e-05 | 14 | 24 | 2 | 10976766 | |
| Pubmed | Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. | 4.77e-05 | 15 | 24 | 2 | 20410501 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.24e-05 | 351 | 24 | 4 | 38297188 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.07e-04 | 134 | 24 | 3 | 25452129 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.43e-04 | 148 | 24 | 3 | 32538781 | |
| Pubmed | 1.59e-04 | 27 | 24 | 2 | 29374058 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.69e-04 | 411 | 24 | 4 | 35182466 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 2.04e-04 | 167 | 24 | 3 | 20362541 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.59e-04 | 857 | 24 | 5 | 25609649 | |
| Pubmed | 2.68e-04 | 35 | 24 | 2 | 22325351 | ||
| Pubmed | Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis. | 2.99e-04 | 37 | 24 | 2 | 12766061 | |
| Pubmed | 2.99e-04 | 37 | 24 | 2 | 22797727 | ||
| Pubmed | An AUTS2-Polycomb complex activates gene expression in the CNS. | 3.16e-04 | 38 | 24 | 2 | 25519132 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.62e-04 | 203 | 24 | 3 | 22083510 | |
| Pubmed | 4.05e-04 | 43 | 24 | 2 | 33472061 | ||
| Pubmed | 4.58e-04 | 220 | 24 | 3 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.58e-04 | 220 | 24 | 3 | 35785414 | |
| Pubmed | 5.08e-04 | 549 | 24 | 4 | 38280479 | ||
| Pubmed | 5.48e-04 | 50 | 24 | 2 | 32068487 | ||
| Interaction | SMARCB1 interactions | 2.59e-06 | 364 | 23 | 6 | int:SMARCB1 | |
| Interaction | RNF2 interactions | 3.54e-05 | 866 | 23 | 7 | int:RNF2 | |
| Interaction | ATN1 interactions | 5.54e-05 | 187 | 23 | 4 | int:ATN1 | |
| Interaction | WWTR1 interactions | 9.69e-05 | 422 | 23 | 5 | int:WWTR1 | |
| Interaction | ERG interactions | 1.10e-04 | 223 | 23 | 4 | int:ERG | |
| Interaction | SNRPC interactions | 1.18e-04 | 440 | 23 | 5 | int:SNRPC | |
| Interaction | KANSL3 interactions | 1.25e-04 | 86 | 23 | 3 | int:KANSL3 | |
| Interaction | GSC interactions | 1.29e-04 | 87 | 23 | 3 | int:GSC | |
| Interaction | MED25 interactions | 1.58e-04 | 93 | 23 | 3 | int:MED25 | |
| Interaction | RERE interactions | 1.58e-04 | 93 | 23 | 3 | int:RERE | |
| Interaction | ZNF608 interactions | 1.58e-04 | 93 | 23 | 3 | int:ZNF608 | |
| Interaction | HDAC1 interactions | 1.68e-04 | 1108 | 23 | 7 | int:HDAC1 | |
| Interaction | KAT8 interactions | 1.68e-04 | 95 | 23 | 3 | int:KAT8 | |
| Interaction | KIFC3 interactions | 1.75e-04 | 252 | 23 | 4 | int:KIFC3 | |
| Interaction | MAD2L1 interactions | 1.75e-04 | 252 | 23 | 4 | int:MAD2L1 | |
| Interaction | SNRPA interactions | 1.81e-04 | 482 | 23 | 5 | int:SNRPA | |
| Interaction | TFCP2L1 interactions | 1.90e-04 | 99 | 23 | 3 | int:TFCP2L1 | |
| Interaction | SNRPB interactions | 2.50e-04 | 517 | 23 | 5 | int:SNRPB | |
| Interaction | HAPSTR1 interactions | 2.63e-04 | 829 | 23 | 6 | int:HAPSTR1 | |
| Interaction | RBFOX2 interactions | 2.77e-04 | 284 | 23 | 4 | int:RBFOX2 | |
| Interaction | TBR1 interactions | 2.80e-04 | 113 | 23 | 3 | int:TBR1 | |
| Interaction | RBBP5 interactions | 2.88e-04 | 287 | 23 | 4 | int:RBBP5 | |
| Interaction | ACTL6A interactions | 2.96e-04 | 289 | 23 | 4 | int:ACTL6A | |
| Interaction | HDAC2 interactions | 3.31e-04 | 865 | 23 | 6 | int:HDAC2 | |
| Interaction | RBM14 interactions | 3.41e-04 | 553 | 23 | 5 | int:RBM14 | |
| Disease | autoimmune thyroid disease | 1.44e-04 | 126 | 24 | 3 | EFO_0006812 | |
| Disease | allergic rhinitis | 1.69e-04 | 133 | 24 | 3 | EFO_0005854 | |
| Disease | respiratory system disease | 2.18e-04 | 145 | 24 | 3 | EFO_0000684 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 3.10e-04 | 32 | 24 | 2 | EFO_0000341, EFO_0004325 | |
| Disease | open-angle glaucoma | 4.89e-04 | 191 | 24 | 3 | EFO_0004190 | |
| Disease | Eczema, allergic rhinitis | 6.90e-04 | 215 | 24 | 3 | EFO_0005854, HP_0000964 | |
| Disease | eosinophil percentage of granulocytes | 8.81e-04 | 234 | 24 | 3 | EFO_0007996 | |
| Disease | lymphocyte count | 9.18e-04 | 1464 | 24 | 6 | EFO_0004587 | |
| Disease | basophil count, eosinophil count | 9.59e-04 | 241 | 24 | 3 | EFO_0004842, EFO_0005090 | |
| Disease | allergic disease | 1.17e-03 | 258 | 24 | 3 | MONDO_0005271 | |
| Disease | synophrys measurement | 1.40e-03 | 68 | 24 | 2 | EFO_0007906 | |
| Disease | allergic disease, age at onset | 1.52e-03 | 71 | 24 | 2 | EFO_0004847, MONDO_0005271 | |
| Disease | hypothyroidism | 1.54e-03 | 284 | 24 | 3 | EFO_0004705 | |
| Disease | age of onset of asthma | 1.88e-03 | 79 | 24 | 2 | OBA_2001001 | |
| Disease | asthma, allergic disease | 1.88e-03 | 79 | 24 | 2 | MONDO_0004979, MONDO_0005271 | |
| Disease | Eczema | 1.97e-03 | 310 | 24 | 3 | HP_0000964 | |
| Disease | childhood onset asthma | 2.44e-03 | 334 | 24 | 3 | MONDO_0005405 | |
| Disease | Inhalant adrenergic use measurement | 2.76e-03 | 96 | 24 | 2 | EFO_0009941 | |
| Disease | eosinophil percentage of leukocytes | 2.88e-03 | 746 | 24 | 4 | EFO_0007991 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 3.05e-03 | 101 | 24 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Vitiligo | 3.05e-03 | 101 | 24 | 2 | EFO_0004208 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.11e-03 | 364 | 24 | 3 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | lymphocyte measurement | 4.06e-03 | 117 | 24 | 2 | EFO_0803546 | |
| Disease | asthma, Eczema, allergic rhinitis | 4.34e-03 | 121 | 24 | 2 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 5.06e-03 | 131 | 24 | 2 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 5.06e-03 | 131 | 24 | 2 | C4552091 | |
| Disease | Juvenile arthritis | 5.06e-03 | 131 | 24 | 2 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 5.06e-03 | 131 | 24 | 2 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 5.37e-03 | 135 | 24 | 2 | C0087031 | |
| Disease | cardiovascular disease | 5.87e-03 | 457 | 24 | 3 | EFO_0000319 | |
| Disease | eosinophil count | 6.17e-03 | 1488 | 24 | 5 | EFO_0004842 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEPAPMKSKPPPTYE | 586 | O60885 | |
| YTTEKKPPPPELDMA | 111 | Q8N6N3 | |
| DLPPPPSKAPMKKEN | 1796 | P51610 | |
| PMKKPICKTTEPYAP | 921 | M0R2J8 | |
| PIKAKPQYKPPDDKM | 316 | Q96JE9 | |
| SVASPPPSPAMPKYK | 21 | O75420 | |
| EMAVKMPEKEPPPPY | 216 | Q15012 | |
| APKPPPPIKDSYMMF | 31 | O43513 | |
| KPMSSKPKPPPRKYF | 591 | Q14005 | |
| PPSPKPMKMKNYNKP | 36 | P03928 | |
| MPTPAPPMFDKYPTK | 556 | Q8WXX7 | |
| PPKKFAPVVAPKPKY | 41 | Q93052 | |
| RDMPKPPPKTKIPKS | 271 | O94988 | |
| YPDPSKQKPMAKGPA | 341 | P54577 | |
| PTKKPNSDIYPKPKP | 36 | P55808 | |
| KPPKPPDKPLMPYMR | 61 | Q969G3 | |
| EKPVDPPPFMFKPVK | 546 | Q9P2R6 | |
| KDYDPKASKPLPPAP | 391 | Q15459 | |
| TPPYKDLPPKPGTME | 56 | Q6ZS10 | |
| RIPYPDMEPKPATKK | 121 | Q9P2J8 | |
| PKLYPEFPPKDMCEK | 111 | Q8N0X7 | |
| KPEPEKTSPKPEYPA | 2351 | Q86UP3 | |
| MPPKKDVPVKKPAGP | 1 | P14649 | |
| HKYQKMLEPPPSAKP | 711 | O95235 | |
| TPKLDPTMPPKKKPQ | 1311 | Q702N8 | |
| PEKKPPPKIAWPMKF | 136 | Q8TCI5 |